Recent studies have reported that FOXP3+ T-cell infiltration is associated with poor clinical outcome [17]-[22], whereas others found no significant prognostic role for FOXP3+ infiltration in a large series of breast cancers [23]. Here, FOXP3 is linked to breast carcinoma.